Biotechs and Precision Medicine

The Parexel Podcast | Episode 6: The opportunity for biotechs in precision medicine

3.5.20 -

Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more companies leveraging this approach? In this episode, Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss this conundrum, and what biotechs should be thinking about right from the start, to open up the opportunity for this approach to help bring innovation and new therapies to more patients.  

"This opportunity to learn from both genomics and real-world data will be the core for what makes the next wave of precision medicine impact."

-Angela Qu, Vice President, Genomic Medicine, Parexel

Learn More

Related Content

Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients

Read article

Patients as Partners 2022: Moving from Insights to Action

Read article

Toward more inclusive studies: Reaching and retaining patients from underrepresented communities

Read article

We are always available for a conversation.

*  

We are always available for a conversation.

Submitting...

Communication Preference

Communication Preference